Mechanisms and therapeutic manipulation of retinoic acid signaling in Acute Kidney Injury
Mechanisms and therapeutic manipulation of retinoic acid signaling in Acute Kidney Injury
批准号:
9332756
负责人:
Mark P. de Caestecker
金额:
$42.67万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2021-03-31
关键词:
AcidsAcute Renal Failure with Renal Papillary NecrosisAgonistAnimal ModelAristolochic AcidsBiological ModelsC10Cell Culture TechniquesCellsChronic Kidney FailureClinical TreatmentDNA BindingDevelopmentDiseaseDoseEnd stage renal failureEpithelial CellsFibrosisGenetic TranscriptionHealthcareHourHumanIn VitroInflammationInflammatoryInjuryIschemiaKidneyKidney DiseasesMediatingMetabolismModelingMusObstructionPathway interactionsPatientsPharmaceutical PreparationsPhasePlayPre-Clinical ModelProcessProteinsRecoveryRecovery of FunctionRecruitment ActivityRenal functionReperfusion TherapyReportingRepressionResolutionRetinoic Acid BindingRetinoidsRisk FactorsRoleSeriesSeveritiesSignal PathwaySignal TransductionSiteTestingTherapeuticTissuesTretinoinTubular formationWorkbasechemokinehuman diseaseimprovedin vitro Modelin vivoinjury and repairmacrophagemortalitynephrogenesisnovelnovel therapeuticspre-clinicalreceptorrepairedresponseresponse to injurysystemic toxicitytherapeutic targettissue regenerationtissue repairtreatment response
中文摘要
急性肾损伤(AKI)是一种严重的疾病,涉及肾功能在几个小时内迅速下降到
几天。严重的病例可能导致终末期肾脏疾病,有证据表明AKI是长期肾病的先兆
慢性肾病(CKD)。尽管如此,AKI还没有有针对性的临床治疗方法。具体地说,不存在任何治疗方法
可加速肾功能恢复或减轻损伤后的纤维化和慢性肾脏病。然而,肾脏
具有修复AKI后的固有能力,并有希望改善AKI介导的长期AKI
损伤在于开发新的治疗方法,可以增强组织修复的自然机制,从而减少
AKI后纤维化与慢性肾脏病的关系。巨噬细胞在协调AKI后的损伤和修复过程中发挥核心作用,但
AKI后巨噬细胞依赖修复的内在机制一直知之甚少。在最近的研究中
我们已经证明,维甲酸(RA)信号在调节这种巨噬细胞依赖的修复过程中起着重要作用
AKI后的纤维化和这一途径的治疗操作可能被用来安全地操作这种RA-
对AKI治疗益处的依赖反应。在这项提案中,我们计划进行一系列小鼠和细胞培养研究,以
探索RA信号调节这种反应的机制,并开发一种新的临床前治疗方法
平台,安全有效地增强肾脏局部RA信号通路的激活,以增加
巨噬细胞依赖的组织修复和减少AKI发作后发生长期CKD的可能性。
英文摘要
Acute kidney injury (AKI) is a serious disorder that involves a rapid decline in renal function over a period of hours to
days. Severe cases can result in end-stage renal disease, and evidence suggests that AKI is a precursor to long-term
chronic renal disease (CKD). Despite this, there is no targeted clinical treatment for AKI. Specifically, no therapies exist
that accelerate renal recovery or decrease fibrosis and CKD when administered after injury. However, the kidney
possesses an inherent capacity to repair after AKI, and a promising approach to ameliorate long-term AKI-mediated
damage lies in developing novel therapies that can enhance the natural mechanisms of tissue repair in order to reduce
fibrosis and CKD after AKI. Macrophages play a central role in coordinating the injury and repair process after AKI, but
the intrinsic mechanisms control macrophage-dependent repair after AKI have been poorly understood. In recent studies
we have shown that retinoic acid (RA) signaling plays an important role in regulating this macrophage-dependent repair
and fibrosis after AKI and that therapeutic manipulation of this pathway might be used to safely manipulate this RA-
dependent response for therapeutic benefit for AKI. In this proposal we plan a series of mouse and cell culture studies to
explore the mechanisms by which RA signaling regulates this response, and to develop a novel pre-clinical therapeutic
platform to safely and effectively enhance local activation of the RA signaling pathway in the kidney in order to increase
macrophage-dependent tissue repair and reduce the likelihood of developing long-term CKD after an episode of AKI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB SRC on Acute Kidney Injury: from beside to bench (and back again)
-
批准号:9752908
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2019
-
负责人:Mark P. de Caestecker
-
依托单位:
Vanderbilt Kidney O'brien Center - Enrichment Program
-
批准号:10163171
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2017
-
负责人:Mark P. de Caestecker
-
依托单位:
Mechanisms and therapeutic manipulation of retinoic acid signaling in Acute Kidney Injury
-
批准号:9924588
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2017
-
负责人:Mark P. de Caestecker
-
依托单位:
Mutation Specific Therapies in Patients with HPAH
-
批准号:8518456
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2012
-
负责人:Mark P. de Caestecker
-
依托单位:
Mutation Specific Therapies in Patients with HPAH
-
批准号:8356472
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2012
-
负责人:Mark P. de Caestecker
-
依托单位:
BMP Signaling and Pulmonary Vasoreactivity
-
批准号:7783908
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2010
-
负责人:Mark P. de Caestecker
-
依托单位:
BMP Signaling and Pulmonary Vasoreactivity
-
批准号:8307784
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2010
-
负责人:Mark P. de Caestecker
-
依托单位:
BMP Signaling and Pulmonary Vasoreactivity
-
批准号:8120666
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2010
-
负责人:Mark P. de Caestecker
-
依托单位:
BMP Signaling and Pulmonary Vasoreactivity
-
批准号:8514043
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2010
-
负责人:Mark P. de Caestecker
-
依托单位:
A mouse model of placental insufficiency with abnormal renal medullary patterning
-
批准号:7585522
-
项目类别:
-
资助金额:$22.99万
-
财政年份:2009
-
负责人:Mark P. de Caestecker
-
依托单位:
A mouse model of placental insufficiency with abnormal renal medullary patterning
-
批准号:7754404
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2009
-
负责人:Mark P. de Caestecker
-
依托单位:
Cellular Defects in Familial Pulmonary Hypertension
-
批准号:7140265
-
项目类别:
-
资助金额:$22.42万
-
财政年份:2005
-
负责人:Mark P. de Caestecker
-
依托单位:
Cellular Defects in Familial Pulmonary Hypertension
-
批准号:6957964
-
项目类别:
-
资助金额:$19.02万
-
财政年份:2005
-
负责人:Mark P. de Caestecker
-
依托单位:
Transcriptional Control of Renal Development by CITED1
-
批准号:6721397
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2002
-
负责人:Mark P. de Caestecker
-
依托单位:
Transcriptional Control of Renal Development by CITED1
-
批准号:6845663
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2002
-
负责人:Mark P. de Caestecker
-
依托单位:
Transcriptional Control of Renal Development by CITED1
-
批准号:6464270
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2002
-
负责人:Mark P. de Caestecker
-
依托单位:
Transcriptional Control of Renal Development by CITED1
-
批准号:6623266
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2002
-
负责人:Mark P. de Caestecker
-
依托单位:
Transcriptional Control of Renal Development by CITED1
-
批准号:7016388
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2002
-
负责人:Mark P. de Caestecker
-
依托单位:
Transcriptional Control of Renal Development by CITED1
-
批准号:6801747
-
项目类别:
-
资助金额:$10.57万
-
财政年份:2002
-
负责人:Mark P. de Caestecker
-
依托单位: